Tumor Evasion from T Cell Surveillance

Abstract

An intact immune system is essential to prevent the development and progression of neoplastic cells in a process termed immune surveillance. During this process the innate and the adaptive immune systems closely cooperate and especially T cells play an important role to detect and eliminate tumor cells. Due to the mechanism of central tolerance the frequency of T cells displaying appropriate arranged tumor‐peptide‐specific‐T‐cell receptors is very low and their activation by professional antigen‐presenting cells, such as dendritic cells, is frequently hampered by insufficient costimulation resulting in peripheral tolerance. In addition, inhibitory immune circuits can impair an efficient antitumoral response of reactive T cells. It also has been demonstrated that large tumor burden can promote a state of immunosuppression that in turn can facilitate neoplastic progression. Moreover, tumor cells, which mostly are genetically instable, can gain rescue mechanisms which further impair immune surveillance by T cells. Herein, we summarize the data on how tumor cells evade T‐cell immune surveillance with the focus on solid tumors and describe approaches to improve anticancer capacity of T cells.

Cited by papers we hold 4

• Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view · 2021
  No notice
• CAR-NK Cells in the Treatment of Solid Tumors · 2021
  No notice
• Myc Cooperates with Ras by Programming Inflammation and Immune Suppression · 2017
  No notice
• Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.